BAETS Logo


NICE guidelines on Endocrine disease

Thyroid

REF

NAME (HYPERLINKED)

ISSUE DATE

Published guidance
IPG562 Ultrasound-guided percutaneous radiofrequency ablation for benign thyroid nodules  Jun-16
IPG499 Minimally invasive video-assisted thyroidectomy Aug-14
QP case study BRAFV600E mutation testing for thyroid cancer: avoiding unnecessary surgery Dec-15
IPG255 Intraoperative nerve monitoring during thyroid surgery Mar-08
IPG130 Collagen injection for vocal cord augmentation Jun-05
IPG148 Retrobulbar irradiation for thyroid eye disease Dec-05
ID1059 Lenvatinib and sorafenib for treating differentiated thyroid cancer after radioactive iodine Aug-18
In development
ID 56 Cabozantinib and vandetanib for treating unresectable locally advanced or metastatic medullary thyroid cancer Dec-17
ID1059 Lenvatinib and sorafenib for treating differentiated thyroid cancer after radioactive iodine  Dec-18
ID1079 Selumetinib for treating differentiated thyroid cancer  TBC
Under consultation
NICE guidelines Thyroid disease: assessment and management Dec-19
Clinical Knowledge Summaries
Hyperthyroidism Scenario: Management : covers the management of people with hyperthyroidism, subclinical hyperthyroidism, and Graves’ orbitopathy. Jun-16
Scenario: Pre-conception, pregnancy, and postpartum : covers the management of pre-conception, pregnant, or postpartum women with hyperthyroidism. Jun-16

 

Parathyroid

REF

NAME (HYPERLINKED)

ISSUE DATE

Published guidance
IPG 247 Thoracoscopic excision of mediastinal parathyroid tumours  Dec-17
IPG 501 Minimally invasive video?assisted parathyroidectomy  Aug-14
TA448 Etelcalcetide for treating secondary hyperparathyroidism  Jun-17
TA117 Cinacalcet for the treatment of secondary hyperparathyroidism in patients with end-stage renal disease on maintenance dialysis therapy (TA117) Jan-07
In development
1094 Recombinant human parathyroid hormone for treating hypoparathyroidism  TBC
GID-NG10051 primary hyperparathyroidism: diagnosis, assessment and initial management May-19

 

Adrenal

REF

NAME (HYPERLINKED)

ISSUE DATE

Published guidance
In development
GID – NG10052 Assessment, referral and management of Adrenal dysfunction TBC